How Can We Pursue Equity in Cervical Cancer Prevention With Existing HPV Genotype Differences?
作者信息
Huepenbecker Sarah P, Meyer Larissa A
机构信息
Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
出版信息
J Natl Cancer Inst. 2022 Jun 13;114(6):787-789. doi: 10.1093/jnci/djac035.
Abstract
摘要
相似文献
1
How Can We Pursue Equity in Cervical Cancer Prevention With Existing HPV Genotype Differences?鉴于现有的HPV基因型差异，我们如何在宫颈癌预防中追求公平？
J Natl Cancer Inst. 2022 Jun 13;114(6):787-789. doi: 10.1093/jnci/djac035.
2
Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.人乳头瘤病毒在俄罗斯联邦、前苏联西方国家、高加索地区和中亚的流行情况和型别分布、宫颈癌筛查实践以及疫苗接种实施现状。
Vaccine. 2013 Dec 31;31 Suppl 7:H46-58. doi: 10.1016/j.vaccine.2013.06.043.
3
Cervical cancer prevention: Human papillomavirus testing as primary screening.宫颈癌预防：人乳头瘤病毒检测作为初筛。
Cancer. 2022 Mar 1;128(5):939-943. doi: 10.1002/cncr.34006. Epub 2021 Nov 12.
4
Cervical cancer screening of HPV vaccinated populations: Cytology, molecular testing, both or none.人乳头瘤病毒疫苗接种人群的宫颈癌筛查：细胞学检查、分子检测、两者皆用或两者皆不用。
J Clin Virol. 2016 Mar;76 Suppl 1(Suppl 1):S62-S68. doi: 10.1016/j.jcv.2015.11.020. Epub 2015 Nov 18.
5
Concordance in cervical HPV detection between hybrid capture 2 and HPV GenoArray tests.杂交捕获2代检测法与HPV基因分型检测法在宫颈人乳头瘤病毒检测中的一致性
Asian Pac J Cancer Prev. 2014;15(11):4465-6. doi: 10.7314/apjcp.2014.15.11.4465.
6
Use of Multiplex Polymerase Chain Reaction for Detection of High-Risk Human Papillomavirus Genotypes in Women Attending Routine Cervical Cancer Screening in Harare.多聚酶链反应在哈拉雷常规宫颈癌筛查中检测高危型人乳头瘤病毒基因型的应用。
Intervirology. 2019;62(2):90-95. doi: 10.1159/000502206. Epub 2019 Aug 14.
7
Editorial: Recent Advances in Molecular Detection of Human Papillomavirus and Cervical Cancer Screening.社论：人乳头瘤病毒分子检测及宫颈癌筛查的最新进展
J Clin Virol. 2016 Mar;76 Suppl 1:S1-S2. doi: 10.1016/j.jcv.2015.11.010. Epub 2015 Nov 5.
8
Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe.人乳头瘤病毒流行率和型别分布、在中欧和东欧的宫颈癌筛查做法以及当前疫苗接种实施状况。
Vaccine. 2013 Dec 31;31 Suppl 7:H59-70. doi: 10.1016/j.vaccine.2013.03.029.
9
HPV Genotype Prevalence and Success of Vaccination to Prevent Cervical Cancer.人乳头瘤病毒基因型流行率及预防宫颈癌疫苗接种的成效
Acta Cytol. 2020;64(5):420-424. doi: 10.1159/000506725. Epub 2020 Apr 1.
10
Clinical significance of human papillomavirus genotyping.人乳头瘤病毒基因分型的临床意义。
J Gynecol Oncol. 2016 Mar;27(2):e21. doi: 10.3802/jgo.2016.27.e21.
引用本文的文献
1
Characterization of High-Risk-Other Human Papillomavirus Genotypes in Papanicolaou Tests, High-Grade Squamous Intraepithelial Lesions, and Cervical Cancer.巴氏涂片检查、高级别鳞状上皮内病变和宫颈癌中高危型其他人类乳头瘤病毒基因型的特征分析
Ochsner J. 2024 Fall;24(3):179-183. doi: 10.31486/toj.24.0018.
2
Precision Population Cancer Medicine in Cancer of the Uterine Cervix: A Potential Roadmap to Eradicate Cervical Cancer.子宫颈癌的精准人群癌症医学：根除宫颈癌的潜在路线图。
Cureus. 2024 Feb 6;16(2):e53733. doi: 10.7759/cureus.53733. eCollection 2024 Feb.
3
Updates on HPV Vaccination.人乳头瘤病毒疫苗最新情况
Diagnostics (Basel). 2023 Jan 9;13(2):243. doi: 10.3390/diagnostics13020243.
本文引用的文献
1
Cervical Precancers and Cancers Attributed to HPV Types by Race and Ethnicity: Implications for Vaccination, Screening, and Management.HPV 型别相关的种族和民族的宫颈癌前病变和癌症：对疫苗接种、筛查和管理的影响。
J Natl Cancer Inst. 2022 Jun 13;114(6):845-853. doi: 10.1093/jnci/djac034.
2
Human Papillomavirus Vaccination and Trends in Cervical Cancer Incidence and Mortality in the US.人乳头瘤病毒疫苗接种与美国宫颈癌发病率和死亡率的趋势
JAMA Pediatr. 2022 Mar 1;176(3):313-316. doi: 10.1001/jamapediatrics.2021.4807.
3
Reducing Poverty-Related Disparities in Cervical Cancer: The Role of HPV Vaccination.减少宫颈癌相关的贫困差距：HPV 疫苗接种的作用。
Cancer Epidemiol Biomarkers Prev. 2021 Oct;30(10):1895-1903. doi: 10.1158/1055-9965.EPI-21-0307. Epub 2021 Sep 9.
4
The ASCCP Cervical Cancer Screening Task Force Endorsement and Opinion on the American Cancer Society Updated Cervical Cancer Screening Guidelines.ASCCP 宫颈癌筛查工作组对美国癌症协会更新的宫颈癌筛查指南的认可和意见。
J Low Genit Tract Dis. 2021 Jul 1;25(3):187-191. doi: 10.1097/LGT.0000000000000614.
5
Race- and Age-Related Disparities in Cervical Cancer Mortality.宫颈癌死亡率的种族和年龄差异
J Natl Compr Canc Netw. 2021 Apr 1;19(7):789-795. doi: 10.6004/jnccn.2020.7665.
6
Given a choice between self-sampling at home for HPV testing and standard of care screening at the clinic, what do African American women choose? Findings from a group randomized controlled trial.在自我采样进行 HPV 检测和在诊所进行标准护理筛查之间做出选择，非裔美国女性会选择什么？一项群组随机对照试验的结果。
Prev Med. 2021 Jan;142:106358. doi: 10.1016/j.ypmed.2020.106358. Epub 2020 Dec 16.
7
Mailed self-sample HPV testing kits to improve cervical cancer screening in a safety net health system: protocol for a hybrid effectiveness-implementation randomized controlled trial.邮寄自采样 HPV 检测试剂盒以改善安全网卫生系统中的宫颈癌筛查：一项混合有效性-实施随机对照试验的方案。
Trials. 2020 Oct 21;21(1):872. doi: 10.1186/s13063-020-04790-5.
8
Assessing Impact of HPV Vaccination on Cervical Cancer Incidence among Women Aged 15-29 Years in the United States, 1999-2017: An Ecologic Study.评估 HPV 疫苗接种对 1999-2017 年间美国 15-29 岁女性宫颈癌发病率的影响：一项生态学研究。
Cancer Epidemiol Biomarkers Prev. 2021 Jan;30(1):30-37. doi: 10.1158/1055-9965.EPI-20-0846. Epub 2020 Oct 20.
9
HPV Vaccination and the Risk of Invasive Cervical Cancer.HPV 疫苗接种与浸润性宫颈癌风险。
N Engl J Med. 2020 Oct 1;383(14):1340-1348. doi: 10.1056/NEJMoa1917338.
10
Prevalence and characteristics of HPV vaccine hesitancy among parents of adolescents across the US.美国青少年父母 HPV 疫苗犹豫的流行率和特征。
Vaccine. 2020 Aug 27;38(38):6027-6037. doi: 10.1016/j.vaccine.2020.06.074. Epub 2020 Aug 2.
Zotero 插件